Tags

Type your tag names separated by a space and hit enter

Effects of minocycline and its degradation products on the growth of Microcystis aeruginosa.
Ecotoxicol Environ Saf. 2011 Mar; 74(3):219-24.EE

Abstract

This work aimed to investigate the influence of Microcystis aeruginosa on the rate of minocycline (MNC) removal (abiotic degradation, physical binding or chemical transformation by cells) and the toxicity of MNC and its degradation products to the cyanobacterium. Most of the work was carried out in culture media in the presence or in the absence of M. aeruginosa. The rate of the MNC abiotic degradation in culture media strongly decreased with the increase of the MNC initial concentration. The exudates did not influence the rate of MNC degradation in the media. For concentrations ≥0.48 μM, the rate of the MNC removal from the media was faster in the presence of M. aeruginosa. Biotic MNC removal occurs by both physical binding by the cells (10%) and chemical transformations. EC(50) and EC(20) for MNC on the growth of M. aeruginosa were 0.92 and 0.13 μM, respectively. Interestingly, MNC degradation products might promote M. aeruginosa growth.

Authors+Show Affiliations

CIMAR/CIIMAR, Centro Interdisciplinar de Investigação Marinha e Ambiental, Universidade do Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20965566

Citation

Stoichev, Teodor, et al. "Effects of Minocycline and Its Degradation Products On the Growth of Microcystis Aeruginosa." Ecotoxicology and Environmental Safety, vol. 74, no. 3, 2011, pp. 219-24.
Stoichev T, Baptista MS, Basto MC, et al. Effects of minocycline and its degradation products on the growth of Microcystis aeruginosa. Ecotoxicol Environ Saf. 2011;74(3):219-24.
Stoichev, T., Baptista, M. S., Basto, M. C., Vasconcelos, V. M., & Vasconcelos, M. T. (2011). Effects of minocycline and its degradation products on the growth of Microcystis aeruginosa. Ecotoxicology and Environmental Safety, 74(3), 219-24. https://doi.org/10.1016/j.ecoenv.2010.10.015
Stoichev T, et al. Effects of Minocycline and Its Degradation Products On the Growth of Microcystis Aeruginosa. Ecotoxicol Environ Saf. 2011;74(3):219-24. PubMed PMID: 20965566.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of minocycline and its degradation products on the growth of Microcystis aeruginosa. AU - Stoichev,Teodor, AU - Baptista,Mafalda S, AU - Basto,M Clara P, AU - Vasconcelos,Vitor M, AU - Vasconcelos,M Teresa S D, Y1 - 2010/10/20/ PY - 2010/03/26/received PY - 2010/09/27/revised PY - 2010/10/03/accepted PY - 2010/10/23/entrez PY - 2010/10/23/pubmed PY - 2011/5/24/medline SP - 219 EP - 24 JF - Ecotoxicology and environmental safety JO - Ecotoxicol Environ Saf VL - 74 IS - 3 N2 - This work aimed to investigate the influence of Microcystis aeruginosa on the rate of minocycline (MNC) removal (abiotic degradation, physical binding or chemical transformation by cells) and the toxicity of MNC and its degradation products to the cyanobacterium. Most of the work was carried out in culture media in the presence or in the absence of M. aeruginosa. The rate of the MNC abiotic degradation in culture media strongly decreased with the increase of the MNC initial concentration. The exudates did not influence the rate of MNC degradation in the media. For concentrations ≥0.48 μM, the rate of the MNC removal from the media was faster in the presence of M. aeruginosa. Biotic MNC removal occurs by both physical binding by the cells (10%) and chemical transformations. EC(50) and EC(20) for MNC on the growth of M. aeruginosa were 0.92 and 0.13 μM, respectively. Interestingly, MNC degradation products might promote M. aeruginosa growth. SN - 1090-2414 UR - https://www.unboundmedicine.com/medline/citation/20965566/Effects_of_minocycline_and_its_degradation_products_on_the_growth_of_Microcystis_aeruginosa_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0147-6513(10)00300-3 DB - PRIME DP - Unbound Medicine ER -